Code |
Title |
–
|
Top Categories
|
3 |
Administration
|
3E |
Physiological Systems and Anatomical Regions
|
3E0
|
Introduction
Administration, Physiological Systems and Anatomical Regions, Introduction
|
3E0C |
Eye
|
3E0C3 |
Percutaneous
|
3E0C30 |
Antineoplastic
|
3E0C304
|
Liquid Brachytherapy Radioisotope
Introduction of Liquid Brachytherapy Radioisotope into Eye, Percutaneous Approach
|
3E0C305
|
Other Antineoplastic
Introduction of Other Antineoplastic into Eye, Percutaneous Approach
|
3E0C30M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Eye, Percutaneous Approach
|
3E0C32 |
Anti-infective
|
3E0C328
|
Oxazolidinones
Introduction of Oxazolidinones into Eye, Percutaneous Approach
|
3E0C329
|
Other Anti-infective
Introduction of Other Anti-infective into Eye, Percutaneous Approach
|
3E0C33 |
Anti-inflammatory
|
3E0C33Z
|
No Qualifier
Introduction of Anti-inflammatory into Eye, Percutaneous Approach
|
3E0C3B |
Anesthetic Agent
|
3E0C3BZ
|
No Qualifier
Introduction of Anesthetic Agent into Eye, Percutaneous Approach
|
3E0C3G |
Other Therapeutic Substance
|
3E0C3GC
|
Other Substance
Introduction of Other Therapeutic Substance into Eye, Percutaneous Approach
|
3E0C3H |
Radioactive Substance
|
3E0C3HZ
|
No Qualifier
Introduction of Radioactive Substance into Eye, Percutaneous Approach
|
3E0C3K |
Other Diagnostic Substance
|
3E0C3KZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Eye, Percutaneous Approach
|
3E0C3M |
Pigment
|
3E0C3MZ
|
No Qualifier
Introduction of Pigment into Eye, Percutaneous Approach
|
3E0C3N |
Analgesics, Hypnotics, Sedatives
|
3E0C3NZ
|
No Qualifier
Introduction of Analgesics, Hypnotics, Sedatives into Eye, Percutaneous Approach
|
3E0C3S |
Gas
|
3E0C3SF
|
Other Gas
Introduction of Other Gas into Eye, Percutaneous Approach
|
3E0C3T |
Destructive Agent
|
3E0C3TZ
|
No Qualifier
Introduction of Destructive Agent into Eye, Percutaneous Approach
|
3E0C7 |
Via Natural or Artificial Opening
|
3E0C70 |
Antineoplastic
|
3E0C704
|
Liquid Brachytherapy Radioisotope
Introduction of Liquid Brachytherapy Radioisotope into Eye, Via Natural or Artificial Opening
|
3E0C705
|
Other Antineoplastic
Introduction of Other Antineoplastic into Eye, Via Natural or Artificial Opening
|
3E0C70M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Eye, Via Natural or Artificial Opening
|
3E0C72 |
Anti-infective
|
3E0C728
|
Oxazolidinones
Introduction of Oxazolidinones into Eye, Via Natural or Artificial Opening
|
3E0C729
|
Other Anti-infective
Introduction of Other Anti-infective into Eye, Via Natural or Artificial Opening
|
3E0C73 |
Anti-inflammatory
|
3E0C73Z
|
No Qualifier
Introduction of Anti-inflammatory into Eye, Via Natural or Artificial Opening
|
3E0C7B |
Anesthetic Agent
|
3E0C7BZ
|
No Qualifier
Introduction of Anesthetic Agent into Eye, Via Natural or Artificial Opening
|
3E0C7G |
Other Therapeutic Substance
|
3E0C7GC
|
Other Substance
Introduction of Other Therapeutic Substance into Eye, Via Natural or Artificial Opening
|
3E0C7H |
Radioactive Substance
|
3E0C7HZ
|
No Qualifier
Introduction of Radioactive Substance into Eye, Via Natural or Artificial Opening
|
3E0C7K |
Other Diagnostic Substance
|
3E0C7KZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Eye, Via Natural or Artificial Opening
|
3E0C7M |
Pigment
|
3E0C7MZ
|
No Qualifier
Introduction of Pigment into Eye, Via Natural or Artificial Opening
|
3E0C7N |
Analgesics, Hypnotics, Sedatives
|
3E0C7NZ
|
No Qualifier
Introduction of Analgesics, Hypnotics, Sedatives into Eye, Via Natural or Artificial Opening
|
3E0C7S |
Gas
|
3E0C7SF
|
Other Gas
Introduction of Other Gas into Eye, Via Natural or Artificial Opening
|
3E0C7T |
Destructive Agent
|
3E0C7TZ
|
No Qualifier
Introduction of Destructive Agent into Eye, Via Natural or Artificial Opening
|
3E0CX |
External
|
3E0CX0 |
Antineoplastic
|
3E0CX04
|
Liquid Brachytherapy Radioisotope
Introduction of Liquid Brachytherapy Radioisotope into Eye, External Approach
|
3E0CX05
|
Other Antineoplastic
Introduction of Other Antineoplastic into Eye, External Approach
|
3E0CX0M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Eye, External Approach
|
3E0CX2 |
Anti-infective
|
3E0CX28
|
Oxazolidinones
Introduction of Oxazolidinones into Eye, External Approach
|
3E0CX29
|
Other Anti-infective
Introduction of Other Anti-infective into Eye, External Approach
|
3E0CX3 |
Anti-inflammatory
|
3E0CX3Z
|
No Qualifier
Introduction of Anti-inflammatory into Eye, External Approach
|
3E0CXB |
Anesthetic Agent
|
3E0CXBZ
|
No Qualifier
Introduction of Anesthetic Agent into Eye, External Approach
|
3E0CXG |
Other Therapeutic Substance
|
3E0CXGC
|
Other Substance
Introduction of Other Therapeutic Substance into Eye, External Approach
|
3E0CXH |
Radioactive Substance
|
3E0CXHZ
|
No Qualifier
Introduction of Radioactive Substance into Eye, External Approach
|
3E0CXK |
Other Diagnostic Substance
|
3E0CXKZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Eye, External Approach
|
3E0CXM |
Pigment
|
3E0CXMZ
|
No Qualifier
Introduction of Pigment into Eye, External Approach
|
3E0CXN |
Analgesics, Hypnotics, Sedatives
|
3E0CXNZ
|
No Qualifier
Introduction of Analgesics, Hypnotics, Sedatives into Eye, External Approach
|
3E0CXS |
Gas
|
3E0CXSF
|
Other Gas
Introduction of Other Gas into Eye, External Approach
|
3E0CXT |
Destructive Agent
|
3E0CXTZ
|
No Qualifier
Introduction of Destructive Agent into Eye, External Approach
|